Skip to main content
. Author manuscript; available in PMC: 2013 May 29.
Published in final edited form as: J AIDS Clin Res. 2013 Mar 5;4(193):1000193. doi: 10.4172/2155-6113.1000193

Table 3.

Anti-candidal potency of characterized pooled saliva from the HIV− and HIV+ groups.

Saliva Hst-5 (μg/ml) % killing
HIV+ (M) 4.82* 18.62
HIV+ (L) 1.1 0
HIV− (H) 8.67* 35.86
HIV− (M) 5.62* 19.31
HIV− (L) 2.6 0

Experiments were performed on three separate occasions. (L) % killing was compared with rest of the groups.

*

P<0.05